Tetrahydroquinoxalines acting as bradykinin antagonists
申请人:——
公开号:US20040235849A1
公开(公告)日:2004-11-25
The invention relates to novel tetrahydroquinoxalines and processes for their preparation, their use for the treatment and/or the prophylaxis of diseases, in particular for the treatment and/or prophylaxis of states of pain.
Novel quinoxalinone derivatives as bradykinin B1 antagonists
申请人:——
公开号:US20040132733A1
公开(公告)日:2004-07-08
2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
Iron- or Zinc-Mediated Synthetic Approach to Enantiopure Dihydroquinoxalinones
作者:Dazhi Li、Thierry Ollevier
DOI:10.1002/ejoc.201801639
日期:2019.2.14
A general and efficient synthesis of dihydroquinoxalinones has been developed. The reductive cyclization of N‐(o‐nitroaryl)amino esters was performed by using iron and zinc metal under mild conditions in a water/ethyl acetate mixture. The final products were obtained in moderate to high yields and high enantiomeric purity.
2-Quinoxalinone derivatives as bradykinin antagonists and novel compounds
申请人:Su Dai-Shi
公开号:US20050020591A1
公开(公告)日:2005-01-27
2-Quinoxalinone derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.